From: Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Case | Gender | Age at death | APOE status | Braak stage | Dementia duration (years) |
---|---|---|---|---|---|
AD | 15F:12M | 63–88 | 20ε4+: 5ε4_ | IV-VI | 3–17 |
OC (n = 32) | 16F:16M | 64–97 | 5ε4+: 27ε4_ | 0-III | n/a |
YC (n = 11) | 6F:5M | 26–62 | n/d | n/d | n/a |